In this process, ITGA2 activates fibroblasts to cancer-associated fibroblasts (CAFs), resulting in extensive desmoplasia with ECM deposition39, wherein desmoplasia is a characteristic feature of PDAC and constitutes up to 90% of the tumor volume. The gene discussed is ITGA2; the disease is cancer.